DOXOrubin Hydrochloride Liposome injection recall: Particulate Matter
DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL single-dose vials, Sterile, Rx only, Manufactured for: Northstar Rx LLC.…
Why was DOXOrubin Hydrochloride Liposome injection recalled?
Presence of Particulate matter: Particulate matter identified as glass.
What should I do if I have this product?
The recall is ongoing. Follow the firm and FDA instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot HAG2581B, expires: 05/31/2027
- Product
- DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL single-dose vials, Sterile, Rx only, Manufactured for: Northstar Rx LLC.…
- Recalling firm
- SUN PHARMACEUTICAL INDUSTRIES INC
- Quantity
- 675 vials
- Distribution
- U.S. Nationwide
- Recall date
- June 17, 2026
- Classification
- Class I
- Status
- Ongoing
- Agency
- FDA (drug)